Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
McKesson is a medical distribution business based in the US. McKesson stocks (MCK.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $357.78 – an increase of 3.24% over the previous week. McKesson employs 58,000 staff and has a trailing 12-month revenue of around $273.9 billion.
Finder Award
Interactive Brokers
National Bank Direct Brokerage
| Latest market close | $357.78 |
|---|---|
| 52-week range | $297.37 - $400.60 |
| 50-day moving average | $357.62 |
| 200-day moving average | $357.40 |
| Wall St. target price | $429.75 |
| PE ratio | 16.4061 |
| Dividend yield | $2.02 (0.61%) |
| Earnings per share (TTM) | $21.77 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $357.78 from 2023-03-30
| 1 week (2023-03-24) | 3.24% |
|---|---|
| 1 month (2023-03-03) | 3.50% |
| 3 months (2022-12-30) | -4.62% |
| 6 months (2022-09-30) | 5.27% |
| 1 year (2022-03-27) | N/A |
|---|---|
| 2 years (2021-03-31) | 83.44% |
| 3 years (2020-03-31) | 164.51% |
| 5 years (2018-03-29) | 153.98% |
Valuing McKesson stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of McKesson's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $273.9 billion |
|---|---|
| Operating margin TTM | 1.54% |
| Gross profit TTM | $13.1 billion |
| Return on assets TTM | 4.17% |
| Return on equity TTM | 0% |
| Profit margin | 1.15% |
| Book value | $-17.93 |
| Market capitalisation | $49.3 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like McKesson.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 23.8
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and McKesson's overall score of 23.8 (as at 01/01/2019) is pretty good – landing it in it in the 26th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like McKesson is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 9.12/100
McKesson's environmental score of 9.12 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that McKesson is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 17.15/100
McKesson's social score of 17.15 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that McKesson is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 12.53/100
McKesson's governance score puts it squarely in the 8th percentile of companies rated in the same sector. That could suggest that McKesson is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 4/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. McKesson scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that McKesson has a damaged public profile.
Dividend payout ratio: 8.49% of net profits
Recently McKesson has paid out, on average, around 8.49% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.61% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), McKesson shareholders could enjoy a 0.61% return on their shares, in the form of dividend payments. In McKesson's case, that would currently equate to about $2.02 per share.
While McKesson's payout ratio might seem low, this can signify that McKesson is investing more in its future growth.
McKesson's most recent dividend payout was on 3 April 2023. The latest dividend was paid out to all shareholders who bought their shares by 28 February 2023 (the "ex-dividend date").
McKesson's shares were split on a 2:1 basis on 5 January 1998. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your McKesson shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for McKesson shares which in turn could have impacted McKesson's share price.
Over the last 12 months, McKesson's shares have ranged in value from as little as $297.3725 up to $400.6021. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while McKesson's is 0.5917. This would suggest that McKesson's shares are less volatile than average (for this exchange).
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U. S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U. S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…Everything we know about the Neuraxis IPO plus information on how to buy in.
Everything we know about the Brera IPO plus information on how to buy in.
Everything we know about the TXO Energy IPO plus information on how to buy in.
Your guide to how ETFs work and whether this type of investment is right for you.
Steps to owning and managing TXG stock, with 24-hour and historical pricing before you buy.
The best stock trading app for beginners is easy to use and offers free trades.
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
An healthcare company, NFT tech developer and baby products retailer are among the IPOs expected to take place this month.
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
The best time to buy stocks could be right after an IPO, during expansion periods or when other investors are buying or selling.
